Last edition
News about "Motixafortide"
BioLineRx Gets USPTO Allowance of New Composition of Matter Patent on Motixafortide
The patent strengthens BioLineRx's robust intellectual property (IP) estate and extends its patent protection on motixafortide in the US through December 2041.
Motixafortide | 18/10/2024 | By Aishwarya | 384
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members